3,559.90-3.5 (-0.10%)
26 Aug, 12:00 AM

Annual Reports and Financial Documents

Ajanta Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Ajanta Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201119 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 19, 2026 for Ravi Agrawal, trustee ....
  2. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201114 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Ravi Agrawal, trustee ....
  3. General5 Aug 2026
    Participation In Investor Conference
    Pls find enclosed Intimation w.r.t participation in Investor Conference
  4. Newspaper Publication31 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.
  5. Analyst / Investor Meet30 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Pls find enclosed Audio Recording of Earnings Call
  6. Allotment of ESOP / ESPS30 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Pls find enclosed ESOP Allotment
  7. Record Date30 Jul 2026
    Record Date Intimation For Dividend
    PFA record date intimation
  8. Dividend30 Jul 2026
    Corporate Action-Board approves Dividend
    PFA Dividend Intimation
  9. Outcome of Board Meeting30 Jul 2026
    Board Meeting Outcome for BM Outcome
    Board Meeting Outcome
  10. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201129 Jul 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 29, 2026 for Aayush Agrawal, trustee ....
  11. Analyst / Investor Meet21 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pls find enclosed Revised Investor Call Intimation
  12. Analyst / Investor Meet20 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pls fine enclosed Investor Call Intimation
  13. Board Meeting20 Jul 2026
    Update on board meeting
    Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Update on board meeting
  14. Board Meeting20 Jul 2026
    Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30Th July 2026.
    Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Financial Results for the quarter ....
  15. AGM17 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Pls find enclosed voting and scrutinizer''s report w.r.t to 47th AGM held on 16.07.2026.
  16. AGM16 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Pls find enclosed AGM Proceedings
  17. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201114 Jul 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Ravi Agrawal, trustee ....
  18. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 20118 Jul 2026
    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 08, 2026 for Aayush Agrawal, ....
  19. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Pls find enclosed Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2026.
  20. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 20113 Jul 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd

Frequently Asked Questions

Where can I download the annual report of Ajanta Pharma Ltd.?
Annual reports of Ajanta Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Ajanta Pharma Ltd.?
Quarterly earnings results and presentations of Ajanta Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Ajanta Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Ajanta Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Ajanta Pharma Ltd.?
Investor presentations and annual day presentations of Ajanta Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Ajanta Pharma Ltd.?
Corporate announcements and regulatory filings of Ajanta Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Ajanta Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Ajanta Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Ajanta Pharma Ltd.?
The ISIN (International Securities Identification Number) of Ajanta Pharma Ltd. is INE031B01049. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Ajanta Pharma Ltd. listed?
Ajanta Pharma Ltd. is listed on NSE and BSE. The NSE symbol is AJANTPHARM and the BSE code is -.
Where can I find the shareholding pattern of Ajanta Pharma Ltd.?
The quarterly shareholding pattern of Ajanta Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Ajanta Pharma Ltd. on Sharpely?
Share price data for Ajanta Pharma Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.